Therapy

Reason

CSL Behring has initiated a Class II voluntary recall of one batch of Mononine due to a manufacturing deviation that occurred during the filling process.

Action

Pharmacies:
Immediately quarantine inventory of the affected product under your direct control and contact your supplier to arrange for return of the identified product.

Patients:
Patients are encouraged to contact their pharmacy regarding their individual prescription and to contact their physician about their treatment plan and potential alternative therapy options.

Other Information

This product recall is being conducted with the knowledge of the Food and Drug Administration.

For Medical Inquiries please contact CSL Behring Medical Information via phone at 1-800-504-5434 or via email at MedinfoNA@cslbehring.com.